Document is current
Any future updates will be listed below
-
Authors
Galeano Niño, Jorge Luis
Wu, Hanrui
LaCourse, Kaitlyn D.
Kempchinsky, Andrew G. https://orcid.org/0000-0002-4984-9684
Baryiames, Alexander
Barber, Brittany
Futran, Neal
Houlton, Jeffrey
Sather, Cassie
Sicinska, Ewa
Taylor, Alison
Minot, Samuel S. https://orcid.org/0000-0003-1639-3905
Johnston, Christopher D. https://orcid.org/0000-0002-6765-2383
Bullman, Susan https://orcid.org/0000-0002-7713-0810
- License Information
-
More Information
Article History
Received: 9 March 2022
Accepted: 10 October 2022
First Online: 16 November 2022
Competing interests
: S.B. has consulted for GlaxoSmithKline and BiomX. C.D.J. has consulted for Series Therapeutics and Azitra. S.B. is an inventor on US patent application no. PCT/US2018/042966, submitted by the Broad Institute and Dana-Farber Cancer Institute, which covers the targeting of <i>Fusobacterium</i> for the treatment of colorectal cancer. K.D.L. is currently employed by NanoString Technologies. The remaining authors declare no competing interests.
